Concepedia

Publication | Open Access

Combined elevation of TRIB2 and MAP3K1 indicates poor prognosis and chemoresistance to temozolomide in glioblastoma

DOIFull Paper Access

48

Citations

30

References

2019

Year

Jia Wang, Jie Zuo, Alafate Wahafu, Mao‐de Wang, Rui-Chun Li, Wanfu Xie
CNS Neuroscience & Therapeutics

Abstract

Combined elevation of TRIB2 and MAP3K1 could be novel prognostic biomarkers and potential therapeutic targets to evaluate the malignancy and long-term outcomes of GBM.

References

YearCitations

Page 1